Xenetic Biosciences
(NASDAQ) XBIO
Xenetic Biosciences Financials at a Glance
Market Cap
$7.23M
Revenue (TTM)
$2.98M
Net Income (TTM)
$2.68M
EPS (TTM)
$-1.62
P/E Ratio
-1.95
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$3.16
Volume
313
Open
$3.12
Price
$3.16
Volume
313
Open
$3.12
Previous Close
$3.16
Daily Range
$3.01 - $3.16
52-Week Range
$1.90 - $13.93
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$3.16
Volume
313
Open
$3.12
Previous Close
$3.16
Daily Range
$3.01 - $3.16
52-Week Range
$1.90 - $13.93
XBIO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xenetic Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
James F. Parslow, MBA, CPA
Website
www.xeneticbio.comHeadquarters
Framingham, MA 01701, US
XBIO Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-95%
Net Income Margin
-90%
Return on Equity
-40%
Return on Capital
-38%
Return on Assets
-32%
Earnings Yield
-51.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.23M
Shares Outstanding
2.29M
Volume
313
Short Interest
0.00%
Avg. Volume
24.79K
Financials (TTM)
Gross Profit
$2.98M
Operating Income
$2.83M
EBITDA
$2.83M
Operating Cash Flow
$2.29M
Capital Expenditure
$0.00
Free Cash Flow
$2.29M
Cash & ST Invst.
$7.88M
Total Debt
$0.00
Xenetic Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$766.30K
+18.1%
Gross Profit
$766.30K
+18.1%
Gross Margin
100.00%
N/A
Market Cap
$7.23M
N/A
Market Cap/Employee
$3.61M
N/A
Employees
2
N/A
Net Income
$579.08K
+45.1%
EBITDA
$623.03K
+43.3%
Quarterly Fundamentals
Net Cash
$7.88M
+27.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-32.05%
N/A
Return on Invested Capital
-38.33%
N/A
Free Cash Flow
$242.68K
+64.0%
Operating Cash Flow
$242.68K
+64.0%